Molecular mechanism of moderate insulin resistance in adiponectin-knockout mice.
Adiponectin has been proposed to act as an antidiabetic adipokine, suppressing gluconeogenesis and stimulating fatty acid oxidation in the liver and skeletal muscle. Although adiponectin-knockout (adipo(-/-)) mice are known to exhibit insulin resistance, the degrees of insulin resistance and glucose intolerance are unexpectedly only moderate. In this study, the adipo(-/-) mice showed hepatic, but not muscle, insulin resistance. insulin-stimulated phosphorylation of IRS-1 and IRS-2 was impaired, the IRS-2 protein level was decreased, and insulin-stimulated phosphorylation of Akt was decreased in the liver of the adipo(-/-) mice. However, the triglyceride content in the liver was not increased in these mice, despite the decrease in the PPARalpha expression involved in lipid combustion, since the expressions of lipogenic genes such as SREBP-1 and SCD-1 were decreased in association with the increased leptin sensitivity. Consistent with this, the down-regulation SREBP-1 and SCD-1 observed in the adipo(-/-) mice was no longer observed, and the hepatic triglyceride content was significantly increased in the adiponectin leptin double-knockout (adipo(-/-)ob/ob) mice. On the other hand, the triglyceride content in the skeletal muscle was significantly decreased in the adipo(-/-) mice, probably due to up-regulated AMPK activity associated with the increased leptin sensitivity. In fact, these phenotypes in the skeletal muscle of these mice were no longer observed in the adipo(-/-)ob/ob mice. In conclusion, adipo(-/-) mice showed impaired insulin signaling in the liver to cause hepatic insulin resistance, however, no increase in the triglyceride content was observed in either the liver or the skeletal muscle, presumably on account of the increased leptin sensitivity.
Yano
Wataru
W
Department of Diabetes and Metabolic Disease, Graduate School of Medicine, University of Tokyo, Tokyo, Japan.
Kubota
Naoto
N
Itoh
Shinsuke
S
Kubota
Tetsuya
T
Awazawa
Motoharu
M
Moroi
Masao
M
Sugi
Kaoru
K
Takamoto
Iseki
I
Ogata
Hitomi
H
Tokuyama
Kumpei
K
Noda
Tetsuo
T
Terauchi
Yasuo
Y
Ueki
Kohjiro
K
Kadowaki
Takashi
T
D052242:Adiponectin / Q000235:genetics; D000818:Animals; D015536:Down-Regulation; D015309:Glucose Clamp Technique; D007328:Insulin / Q000378:metabolism; D007333:Insulin Resistance / Q000235:genetics*; D020738:Leptin / Q000235:genetics; D050155:Lipogenesis / Q000235:genetics; D008099:Liver / Q000737:chemistry / Q000378:metabolism; D008297:Male; D051379:Mice; D018345:Mice, Knockout; D008820:Mice, Obese; D015398:Signal Transduction / Q000235:genetics / Q000502:physiology; D014280:Triglycerides / Q000032:analysis
D052242:Adiponectin; C499919:Adipoq protein, mouse; D007328:Insulin; D020738:Leptin; D014280:Triglycerides